CAR T Cell Therapy for Multiple Myeloma market | Size, Share, Growth

CAR T Cell Therapy for Multiple Myeloma Market Research Report

Published: 2025 - January

Report Code: VMR-17733

Region: Global

Request Sample

Customization

Ask an Expert

Enquire Enquire Before Buying

CAR T Cell Therapy for Multiple Myeloma Market Analysis

The CAR T Cell Therapy for Multiple Myeloma market involves the development and commercialization of personalized immunotherapies designed to treat multiple myeloma, a form of blood cancer. This market leverages chimeric antigen receptor (CAR) T cell technology, where a patient's own T cells are engineered to recognize and attack myeloma cells. The therapeutic area is rapidly advancing, with a focus on overcoming challenges such as relapsed/refractory multiple myeloma and improving patient outcomes.

Disruptive Impact and Opportunities:

CAR T cell therapies have the potential to revolutionize the treatment of multiple myeloma by offering durable remissions for patients who have exhausted traditional therapies. Introduction of novel engineered CAR T therapies, with emerging drugs such as PHE 885 and JNJ-68284528, targeting specific antigens and improving efficacy. Simplified administration and optimization of treatment regimens, making CAR T cell therapies increasingly accessible to diverse patient populations. Ongoing advancements in safety profiles, mitigating risks like cytokine release syndrome (CRS) and neurotoxicity, improving the therapeutic index. With an increasing number of approved therapies and ongoing clinical trials, the market is poised for substantial growth as demand for more effective treatments rises.

CAR T Cell Therapy for Multiple Myeloma Market Segmentation: Emerging Drugs

PHE 885
JNJ-68284528

CAR T Cell Therapy for Multiple Myeloma Market Segmentation: Marketed Drugs

Idecabtagene vicleucel (ide-cel, Abecma)
Ciltacabtagene autoleucel (cilta-cel, Carvykti)

Key Companies:

Bluebird bio/Celgene
Janssen Research & Development
Poseida Therapeutics
MolMed S.p.A.
Celgene Corporation
Cartesian Therapeutics
CARsgen Therapeutics
Precision BioSciences

CAR T Cell Therapy for Multiple Myeloma Market Segmentation: By Type

- Autologous CAR T Cell Therapy
- Allogeneic CAR T Cell Therapy

CAR T Cell Therapy for Multiple Myeloma Market Segmentation: By Administration Type

- Intravenous Administration
- Intrathecal Administration (in specific cases)

What’s in It for You?

Comprehensive insights into the CAR T cell therapy market for multiple myeloma.
Detailed analysis of emerging and marketed drugs, providing a clear view of competitive dynamics.
Market trends and forecasts to inform strategic planning and investment decisions.
Identification of key opportunities for innovation and growth in CAR T therapies for myeloma.

Car T Cell Therapy For Multiple Myeloma Market - Executive Summary
1. Introduction
2. Objectives
3. Key Findings
  1. Market Size 2025 & 2030: By Key Country (10MM)
  2. Global Market Size 2025 & 2030: By Key Segment
  3. Key Investments & Startup Analysis
4. Research Methodology
Understanding the Disease
1. Disease Overview
2. Classification
3. Signs and Symptoms
4. Risk Factors
5. Causes
6. Disease Biology & Digital Innovations
7. Stages & Staging System
8. Diagnostic Algorithm
9. Current Treatment Practices & Algorithm
10. Current Standard of Care and Treatment Gaps
11. Patient Demographics and Treatment Pathways
Guidelines
Unmet Needs
Epidemiology and Patient Population
1. Epidemiology Key Findings
2. Assumptions and Rationale: 10MM
3. Epidemiology Scenario: 10MM
4. U.S. Epidemiology Scenario
5. EU-5 Epidemiology
  1. U.K. Epidemiology Scenario
  2. Germany Epidemiology Scenario
  3. France Epidemiology Scenario
  4. Italy Epidemiology Scenario
  5. Spain Epidemiology Scenario
6. Japan Epidemiology Scenario
7. China Epidemiology Scenario
8. Australia Epidemiology Scenario
9. India Epidemiology Scenario
Real-world Data & Real-world Evidence
Drug Development Landscape
1. Existing Key Drug Candidate Profiles/ Marketed Therapies
2. Competitive Analysis and Differentiation
3. Overview of Similar/Competing Drugs in Clinical Trials
4. Future Trends and Emerging Drugs
Regulatory Strategy and Potential Challenges
1. Regulatory Pathways in Key Markets
2. Anticipated Regulatory Hurdles and Mitigation Strategies
3. Case Studies in Oncology Drug Regulation
4. Impact of Potential Changes to Regulatory Framework
Commercial Landscape
1. Market Size & Growth Rates
2. Key Approvals & Anticipated Loss of Exclusivity
3. PESTLE & Porter’s Five Forces Analysis
4. Market Shares, Positioning/Ranking
5. Market Drivers
6. Identification of Threats
7. Digital Evolution in Commercialization
Market Segmentation
Pricing, Reimbursement, and Access
1. Competitive Pricing Analysis
2. Reimbursement Landscape and Challenges
3. Strategies for Market Access and Equity
4. Patient Spending/Expenditure Analysis
Future Trends, Disruptions, and Opportunities
1. Analysis of Emerging Trends
2. Technological Impact
3. Impact of Potential Market Disruptors
4. Opportunities for Future Development and Expansion
5. Considerations for Investment Opportunities
Global Market Dynamics
1. Regional Regulatory Disparities
2. Cross-Border Partnership Strategies
3. Global Supply Chain Dynamics
4. Case Studies: Success and Failure in Global Markets
5. Strategies for Global Expansion and Localization
Company Profiles

Download Sample

Full Name *

Job Title *

Company *

Email *

Phone *

Country *

Message

↻

The field with (*) is required.

Choose License Type

Excel Data Pack

2500

Single User

4250

Multi User

5250

Corporate User

6900